Sign inGet started

Salter Malcolm

Insider CIK 1825124 · CCCC Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CCCC C4 Therapeutics, Inc. A Award deriv2024-06-202024-06-2132,500— $032,500SEC↗
CCCC C4 Therapeutics, Inc. A Award deriv2023-06-152023-06-1626,000— $026,000SEC↗
CCCC C4 Therapeutics, Inc. A Award deriv2022-06-222022-06-2323,500— $023,500SEC↗
CCCC C4 Therapeutics, Inc. A Award2022-01-042022-01-18428$31.58 $13.5K11,380SEC↗
CCCC C4 Therapeutics, Inc. S Sale2021-12-172021-12-17755$30.25 $22.8K10,952SEC↗
CCCC C4 Therapeutics, Inc. S Sale2021-11-192021-11-19755$40.11 $30.3K11,707SEC↗
CCCC C4 Therapeutics, Inc. S Sale2021-10-152021-10-15755$44.94 $33.9K12,462SEC↗
CCCC C4 Therapeutics, Inc. A Award2021-10-042021-10-05300$44.99 $13.5K13,217SEC↗
CCCC C4 Therapeutics, Inc. S Sale2021-09-172021-09-21755$49.89 $37.7K12,917SEC↗
CCCC C4 Therapeutics, Inc. S Sale2021-08-202021-08-24755$40.73 $30.8K13,672SEC↗
CCCC C4 Therapeutics, Inc. S Sale2021-07-162021-07-19755$37.37 $28.2K14,427SEC↗
CCCC C4 Therapeutics, Inc. A Award2021-07-022021-07-07339$39.72 $13.5K15,182SEC↗
CCCC C4 Therapeutics, Inc. S Sale2021-06-182021-06-21755$37.19 $28.1K14,843SEC↗
CCCC C4 Therapeutics, Inc. A Award deriv2021-06-152021-06-1723,500— $023,500SEC↗
CCCC C4 Therapeutics, Inc. S Sale2021-05-212021-05-24755$37.12 $28.0K15,598SEC↗
CCCC C4 Therapeutics, Inc. A Award2021-04-052021-04-06359$37.51 $13.5K16,353SEC↗
CCCC C4 Therapeutics, Inc. C Conversion deriv2020-10-062020-10-06100,000— $00SEC↗
CCCC C4 Therapeutics, Inc. C Conversion deriv2020-10-062020-10-0623,809— $00SEC↗
CCCC C4 Therapeutics, Inc. P Buy2020-10-062020-10-061,315$19.00 $25.0K15,994SEC↗
CCCC C4 Therapeutics, Inc. C Conversion2020-10-062020-10-0611,856— $011,856SEC↗
CCCC C4 Therapeutics, Inc. C Conversion2020-10-062020-10-062,823— $014,679SEC↗
CCCC C4 Therapeutics, Inc. A Award deriv2020-10-012020-10-0517,786— $017,786SEC↗